DK46687A - N6-substituerede adenosiner, fremgangsmaade til deres fremstilling og farmaceutisk komposition indeholdende forbindelserne - Google Patents
N6-substituerede adenosiner, fremgangsmaade til deres fremstilling og farmaceutisk komposition indeholdende forbindelserneInfo
- Publication number
- DK46687A DK46687A DK046687A DK46687A DK46687A DK 46687 A DK46687 A DK 46687A DK 046687 A DK046687 A DK 046687A DK 46687 A DK46687 A DK 46687A DK 46687 A DK46687 A DK 46687A
- Authority
- DK
- Denmark
- Prior art keywords
- procedures
- compounds
- preparation
- pharmaceutical composition
- composition containing
- Prior art date
Links
- 150000003838 adenosines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82551386A | 1986-01-31 | 1986-01-31 | |
| US06/936,766 US4755594A (en) | 1986-01-31 | 1986-12-09 | N6 -substituted adenosines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK46687D0 DK46687D0 (da) | 1987-01-29 |
| DK46687A true DK46687A (da) | 1987-08-01 |
Family
ID=27124913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK046687A DK46687A (da) | 1986-01-31 | 1987-01-29 | N6-substituerede adenosiner, fremgangsmaade til deres fremstilling og farmaceutisk komposition indeholdende forbindelserne |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4755594A (da) |
| EP (1) | EP0232813A3 (da) |
| KR (1) | KR910000602B1 (da) |
| AU (1) | AU592728B2 (da) |
| CA (1) | CA1270821A (da) |
| DK (1) | DK46687A (da) |
| FI (1) | FI870371A7 (da) |
| NO (1) | NO165843C (da) |
| NZ (1) | NZ219128A (da) |
| PH (1) | PH23342A (da) |
| PT (1) | PT84226B (da) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5063233A (en) * | 1986-11-14 | 1991-11-05 | Ciba-Geigy Corporation | N9 -cyclopentyl-substituted adenine derivatives useful as adenosine receptor agonists |
| US4954504A (en) * | 1986-11-14 | 1990-09-04 | Ciba-Geigy Corporation | N9 -cyclopentyl-substituted adenine derivatives having adenosine-2 receptor stimulating activity |
| US4968697A (en) * | 1987-02-04 | 1990-11-06 | Ciba-Geigy Corporation | 2-substituted adenosine 5'-carboxamides as antihypertensive agents |
| US5034381A (en) * | 1988-01-07 | 1991-07-23 | Ciba-Geigy Corporation | 2-(substituted amino) adenosines as antihypertensives |
| GB2226027B (en) * | 1988-12-13 | 1992-05-20 | Sandoz Ltd | Adenosine derivatives,their production and use |
| US5055569A (en) * | 1989-10-19 | 1991-10-08 | G. D. Searle & Co. | N-(6)-substituted adenosine compounds |
| US5681941A (en) * | 1990-01-11 | 1997-10-28 | Isis Pharmaceuticals, Inc. | Substituted purines and oligonucleotide cross-linking |
| US5677290A (en) * | 1990-05-10 | 1997-10-14 | Fukunaga; Atsuo F. | Therapeutic use of adenosine compounds as surgical anesthetics |
| US6180616B1 (en) | 1990-05-10 | 2001-01-30 | Atsuo F. Fukunaga | Use of purine receptor agonists to alleviate or normalize physiopathologically excited sensory nerve function |
| US6004945A (en) * | 1990-05-10 | 1999-12-21 | Fukunaga; Atsuo F. | Use of adenosine compounds to relieve pain |
| SG80526A1 (en) * | 1990-09-25 | 2001-05-22 | Rhone Poulenc Rorer Int | Compounds having antihypertensive and anti- ischemic properies |
| US5561134A (en) * | 1990-09-25 | 1996-10-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| FR2685918B1 (fr) * | 1992-01-08 | 1995-06-23 | Union Pharma Scient Appl | Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant. |
| FR2687678B1 (fr) * | 1992-01-31 | 1995-03-31 | Union Pharma Scient Appl | Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant. |
| US5589467A (en) * | 1993-09-17 | 1996-12-31 | Novo Nordisk A/S | 2,5',N6-trisubstituted adenosine derivatives |
| US6376472B1 (en) * | 1996-07-08 | 2002-04-23 | Aventis Pharmaceuticals, Inc. | Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| TW528755B (en) | 1996-12-24 | 2003-04-21 | Glaxo Group Ltd | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| US6110902A (en) * | 1997-06-23 | 2000-08-29 | Moehler; Hanns | Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine |
| US6232463B1 (en) | 1997-10-09 | 2001-05-15 | Isis Pharmaceuticals, Inc. | Substituted purines and oligonucleotide cross-linking |
| WO1999031075A1 (en) * | 1997-12-16 | 1999-06-24 | Warner-Lambert Company | 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| YU44900A (sh) | 1998-01-31 | 2003-01-31 | Glaxo Group Limited | Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola |
| CN1313861A (zh) | 1998-06-23 | 2001-09-19 | 葛兰素集团有限公司 | 2-(嘌呤-9-基)-四氢呋喃-3,4-二醇衍生物 |
| US6294522B1 (en) * | 1999-12-03 | 2001-09-25 | Cv Therapeutics, Inc. | N6 heterocyclic 8-modified adenosine derivatives |
| MY125533A (en) * | 1999-12-06 | 2006-08-30 | Bristol Myers Squibb Co | Heterocyclic dihydropyrimidine compounds |
| US20030008841A1 (en) * | 2000-08-30 | 2003-01-09 | Rene Devos | Anti-HCV nucleoside derivatives |
| TW200307539A (en) * | 2002-02-01 | 2003-12-16 | Bristol Myers Squibb Co | Cycloalkyl inhibitors of potassium channel function |
| US7265111B2 (en) * | 2002-06-27 | 2007-09-04 | Sanofi-Aventis Deutschland Gmbh | Adenosine analogues and their use as pharmaceutical agents |
| EP1375508A1 (en) * | 2002-06-27 | 2004-01-02 | Aventis Pharma Deutschland GmbH | N6-substituted adenosine analogues and their use as pharmaceutical agents |
| AR049384A1 (es) | 2004-05-24 | 2006-07-26 | Glaxo Group Ltd | Derivados de purina |
| GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
| CN101857622B (zh) * | 2009-04-07 | 2014-12-03 | 中国医学科学院药物研究所 | 一种腺苷衍生物及其制备方法和应用 |
| WO2018140734A1 (en) * | 2017-01-27 | 2018-08-02 | Academia Sinica | Compound with analgesic effect for use in prevention and treatment of pain |
| KR102308854B1 (ko) * | 2021-02-26 | 2021-10-05 | 퓨쳐메디신 주식회사 | 카보사이클릭 뉴클레오사이드 유도체를 포함하는 코로나바이러스감염증-19 예방 및 치료용 약학적 조성물 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE329623B (da) * | 1967-06-08 | 1970-10-19 | C F Boehringer Soehne Gmbh | |
| GB1336949A (en) * | 1971-07-06 | 1973-11-14 | Boehringer Mannheim Gmbh | Adenosine derivatives |
| DE2406587A1 (de) * | 1974-02-12 | 1975-08-21 | Klinge Co Chem Pharm Fab | Hypolipaemisch wirksame adenosinderivate |
| DE3019322A1 (de) * | 1980-05-21 | 1981-12-03 | Merck Patent Gmbh, 6100 Darmstadt | Psychopharmakon sowie verwendung von adenosinderivaten |
| CA1239397A (en) * | 1983-08-01 | 1988-07-19 | James A. Bristol | N.sup.6-substituted adenosines |
| DE3406533A1 (de) * | 1984-02-23 | 1985-08-29 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verwendung von adenosin-derivaten als antiallergica und arzneimittel, die diese enthalten |
| US4657898A (en) * | 1984-06-22 | 1987-04-14 | Warner-Lambert Company | N6 -substituted adenosines and method of use |
| US4657897A (en) * | 1984-06-22 | 1987-04-14 | Warner-Lambert Company | N6 -substituted adenosines for treating pain |
| US4593019A (en) * | 1984-10-26 | 1986-06-03 | Warner-Lambert Company | N6 -tricyclic adenosines |
| US4614732A (en) * | 1984-10-26 | 1986-09-30 | Warner-Lambert Company | N6 -acenaphthyl adenosines and analogs thereof |
| CA1254888A (en) * | 1984-10-26 | 1989-05-30 | Bharat Trivedi | N.sup.6-bicycloadenosines |
| US4616003A (en) * | 1984-10-26 | 1986-10-07 | Warner-Lambert Company | N6 -dihydroxypropyladenosines |
| WO1988003147A1 (en) * | 1986-10-31 | 1988-05-05 | Warner-Lambert Company | Selected n6-substituted adenosines having selective a2 binding activity |
| LU87181A1 (fr) * | 1987-04-06 | 1988-11-17 | Sandoz Sa | Nouveaux derives de l'acide furannuronique,leur preparation et leur utilisation comme medicaments |
-
1986
- 1986-12-09 US US06/936,766 patent/US4755594A/en not_active Expired - Fee Related
-
1987
- 1987-01-12 CA CA000527145A patent/CA1270821A/en not_active Expired - Fee Related
- 1987-01-23 AU AU67972/87A patent/AU592728B2/en not_active Ceased
- 1987-01-28 FI FI870371A patent/FI870371A7/fi not_active Application Discontinuation
- 1987-01-28 PH PH34780A patent/PH23342A/en unknown
- 1987-01-29 DK DK046687A patent/DK46687A/da not_active Application Discontinuation
- 1987-01-30 NZ NZ219128A patent/NZ219128A/en unknown
- 1987-01-30 EP EP87101268A patent/EP0232813A3/en not_active Withdrawn
- 1987-01-30 PT PT84226A patent/PT84226B/pt not_active IP Right Cessation
- 1987-01-30 KR KR1019870000713A patent/KR910000602B1/ko not_active Expired
- 1987-01-30 NO NO870390A patent/NO165843C/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR870007177A (ko) | 1987-08-17 |
| KR910000602B1 (ko) | 1991-01-28 |
| NO165843B (no) | 1991-01-07 |
| PH23342A (en) | 1989-07-14 |
| EP0232813A3 (en) | 1989-03-22 |
| NZ219128A (en) | 1990-01-29 |
| EP0232813A2 (en) | 1987-08-19 |
| AU6797287A (en) | 1987-08-06 |
| CA1270821A (en) | 1990-06-26 |
| US4755594A (en) | 1988-07-05 |
| DK46687D0 (da) | 1987-01-29 |
| AU592728B2 (en) | 1990-01-18 |
| NO165843C (no) | 1991-04-17 |
| FI870371A7 (fi) | 1987-08-01 |
| FI870371A0 (fi) | 1987-01-28 |
| PT84226A (en) | 1987-02-01 |
| NO870390L (no) | 1987-08-03 |
| PT84226B (pt) | 1989-05-31 |
| NO870390D0 (no) | 1987-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK46687D0 (da) | N6-substituerede adenosiner, fremgangsmaade til deres fremstilling og farmaceutisk komposition indeholdende forbindelserne | |
| DK488885D0 (da) | 9-amino-1,2,3,4-tetrahydroacridin-1-ol og beslaegtede forbindelser, enfremgangsmaade til deres fremstilling og deres anvendelse som laegemidler | |
| DK573384D0 (da) | Sphingosinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende disse derivater | |
| DK362787A (da) | Benzensulfonamido-indanylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling | |
| IL88765A (en) | N-hydroxycycloalkyl or n-hydroxycycloalkenyl- substituted adenosine derivatives, methods for their preparation and pharmaceutical compositions, including antilipolytic compositions, containing the same | |
| DK590185A (da) | Imidazoderivater, deres fremstilling og laegemiddel indeholdende saadanne forbindelser | |
| DK408186D0 (da) | Podophyllotoxin og derivater deraf, fremgangsmaader til deres fremstilling og anvendelse samt farmaceutiske praeparater indeholdende forbindelserne | |
| DK371584D0 (da) | N6-substituerede adenosiner, fremgangsmaade til deres fremstilling sam deres anvendelse | |
| DK250387D0 (da) | Di- og tetrahydroisoquinolin-derivater, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne | |
| DK592685A (da) | Imidazoderivater, deres fremstilling og laegemiddel indeholdende saadanne forbindelser | |
| DK435588A (da) | Aralkylaminoalkoxyphenylderivater, fremgangsmaade til deres fremstilling og midler indeholdende disse | |
| DK133587D0 (da) | 2-heterocyclylthio-penemer, deres anvendelse og farmaceutisk komposition indeholdende forbindelserne | |
| DK457787A (da) | Sulfonamidoethylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling | |
| FI874414A0 (fi) | Kontrollerat frigoerande farmaceutiska kompositioner. | |
| DK586188A (da) | Kondenserede diazepinoner, fremgangsmaade til deres fremstilling og laegemidler med indhold af saadanne forbindelser | |
| DK488585A (da) | N6- substituerede adenosinforbindelser, deres fremstilling og farmaceutiske praeparater indeholdende saadanne forbindelser | |
| DE3781483D1 (de) | Pharmazeutische zusammensetzung zum schutz von gehirnzellen. | |
| DK617684D0 (da) | 1,3-dioxolanylderivater, fremgangsmaade til deres fremstilling, deres anvendelse og laegemidler indeholdende disse forbindelser | |
| DK133387D0 (da) | 5-fluoruracilderivater og fremgangsmaade til deres fremstilling | |
| DK512185A (da) | 3,4-diazolderivater, fremgangsmaade til deres fremstilling og laegemidler, der indeholder disse forbindelser | |
| DK110785A (da) | Carboxyalkyldipeptidderivater, fremgangsmaade til deres fremstilling, midler indeholdende dem og deres anvendelse | |
| DK163985A (da) | Antivirale purinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne | |
| DK339285D0 (da) | Pyridinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne | |
| DK127086D0 (da) | Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske konpositioner, der indeholder disse forbindelser | |
| DK354688A (da) | Benzooe5,6aacycloheptapyridiner, kompositioner og fremgangsmaader til deres anvendelse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AHS | Application shelved for other reasons than non-payment |